PHOENIX, Jan. 8, 2019 /PRNewswire/ — Pinnacle Transplant Technologies, a regenerative medical company with a focus on providing safe, quality driven products to improve lives through innovation, collaboration, and teamwork, today announced the addition of Roger Rose as Chief Executive Officer.
“I am excited to join the Pinnacle executive team as CEO,” Rose said. “Partnering with Organ Procurement organizations to maximize the gift of donation and provide precious implants for recipients is very rewarding. I believe Pinnacle has the opportunity to be the premier implant supplier in the Southwest. In the coming month I will be focused on assessing the company’s structure and strategy, and I look forward to continued growth as we expand our presence.”
Rose replaces Keith Stoneback who served as CEO of Pinnacle November, 2017. We would like to thank Keith for all his contributions to our success.
“We are pleased to have Roger join our team as CEO,” said Gabe Hyams, Co-founder of Pinnacle. “He has a proven track record in the regenerative medicine space and in leading teams like ours at a critical stage of growth.”
Rose brings more than 30 years of healthcare industry experience. Roger is a senior healthcare executive with C-Suite level experience. He is known for delivering world-class solutions that connect strategic business and financial goals with optimal clinical outcomes. He has extensive experience and a consistent record of accomplishments in both domestic and international markets delivering excellent financial results. He is well-versed in assisting organizations create a winning strategy. Roger is experienced developing best-in-class products and services resulting in numerous positive outcomes.
Most recent roles include President RTI Donor Services and Executive Vice President RTI Surgical. He developed and led the Cardiothoracic, OEM and Sports Medicine businesses while at RTI. His career includes time at J&J, Nellcor, Herman Miller, Stryker and RTI Surgical.
About Pinnacle Transplant Technologies, LLC.
Founded in 2010, Pinnacle Transplant Technologies (PTT) recognized the need to establish a processing and distribution facility that would enable medical professionals to acquire safe quality allograft tissue for transplant. The company manufactures innovative allografts produced to the highest standards of quality and safety.
Pinnacle Transplant Technologies is a multi-service tissue bank dedicated to the ethical participation in the Donate Life ™ process. U.S. Food and Drug Administration (FDA) registered and American Association of Tissue Banks (AATB) accredited, Pinnacle only works with federally chartered Organ Procurement Organizations (OPOs) and agencies accredited by AATB to help provide superior allografts for transplantation, assure transplant patient safety, safeguard our associates, and assure reverence to our donor families.
The company is headquartered in Phoenix, AZ., and its products are available across the U.S. For additional information on the company, please visit www.pinnacletransplant.com.
SOURCE Pinnacle Transplant Technologies, LLC